From: Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
Attribute | Attribute label | Levels |
---|---|---|
Probability of optimal laboratory values | Chance that the treatment keeps your labs within their recommended ranges | ▪ 80 out of 100 (80%) ▪ 60 out of 100 (60%) ▪ 25 out of 100 (25%) |
Probability of symptom relief | Chance that the treatment relieves your SHPT symptoms | ▪ 75 out of 100 (75%) ▪ 35 out of 100 (35%) ▪ 5 out of 100 (5%) |
Risk of hypocalcemia | Risk of low blood calcium | ▪ 0 out of 100 (0%) ▪ 2 out of 100 (2%) ▪ 10 out of 100 (10%) |
Severity of nausea and vomiting | Nausea and vomiting (medication alternatives only) | ▪ None ▪ Mild ▪ Moderate |
Mode of administration | How you receive the medicine (medication alternatives only) | ▪ Given through dialysis line during your regular dialysis treatment ▪ Pill once a week ▪ Pill once a day |
Cost | Out-of-pocket cost of treatment | ▪ $50 per month (medication alternatives only) ▪ $100 per month (medication alternatives only) ▪ $200 per month (medication alternatives only) ▪ $500 one time (surgery only) |